Without insurance, the average retail price for Ozempic is $1,000 to $1,200 a month (around $12,000 or more a year), while Wegovy has a list price of $1,350 for a 28-day supply, which adds up to about $16,200 annually, according to GoodRx
Yeo, Y.H
Other factors, including patient age, gender, body mass index (BMI), and hepatitis C infection, further exacerbate the risk of PTDM. Current management of PTDM remains a challenge, often requiring adjustment immunosuppressant regimens and promoting lifestyle changes
IV therapy is typically covered by insurance only when it is deemed medically necessary and prescribed by a healthcare provider
Theoretical risks Long-term or high-frequency use raises theoretical concerns about copper accumulation